Use of darbepoetin alfa (Aranesp) in pediatric kidney disease

被引：0
|
作者：
McTaggart, S.
Alexander, S.
Craig, J.
Henning, P.
Hodson, E.
Jones, C.
Jureidini, F.
Lewis, D.
Powell, H.
Burke, J.
机构：
[1] Royal Childrens Hosp, Child & Adolescent Renal Serv, Brisbane, Qld, Australia
[2] Univ Queensland, Mater Childrens Hosp, Child & Adolescent Renal Serv, Brisbane, Qld 4101, Australia
[3] Childrens Hosp Westmead, Dept Nephrol, Sydney, NSW, Australia
[4] Royal Childrens Hosp, Dept Nephrol, Melbourne, Vic, Australia
来源：
PEDIATRIC NEPHROLOGY | 2007年 / 22卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1472 / 1472
页数：1
相关论文
共 50 条
  • [31] De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease
    Bradley A. Warady
    John Barcia
    Nadine Benador
    Augustina Jankauskiene
    Kurt Olson
    Ludmila Podracka
    Aleksey Shavkin
    Poyyapakkam Srivaths
    Cynthia J. Wong
    Jeffrey Petersen
    Pediatric Nephrology, 2018, 33 : 125 - 137
  • [32] De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease
    Warady, Bradley A.
    Barcia, John
    Benador, Nadine
    Jankauskiene, Augustina
    Olson, Kurt
    Podracka, Ludmila
    Shavkin, Aleksey
    Srivaths, Poyyapakkam
    Wong, Cynthia J.
    Petersen, Jeffrey
    PEDIATRIC NEPHROLOGY, 2018, 33 (01) : 125 - 137
  • [33] Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations
    Carrera, Fernando
    Burnier, Michel
    CLINICAL KIDNEY JOURNAL, 2009, 2 : I9 - I17
  • [34] Comment on:: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease
    Einarson, Thomas
    Machado, Marcio
    Walker, John
    Iskedjian, Michael
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (07) : 1571 - 1573
  • [35] Neuroprotective effect of aranesp (Darbepoetin alfa) after cortical impact injury in rats
    Cherian, L
    Robertson, CS
    JOURNAL OF NEUROTRAUMA, 2006, 23 (05) : 793 - 793
  • [36] Use of darbepoetin alfa in haemolytic disease of the fetus and newborn
    Patel, Ravi M.
    Ohls, Robin
    LANCET HAEMATOLOGY, 2023, 10 (12): : E943 - E945
  • [37] Dose efficiency of aranesp (darbepoetin alfa) compared with epoetin alfa/beta in dialysis patients - A meta analysis
    Torres, Pablo Urena
    Maetzel, Andreas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 193 - 194
  • [38] Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease
    Chen, Han-Hsiang
    Tarng, Der-Cherng
    Lee, Kun-Feng
    Wu, Chih-Jen
    Chen, Yi-Chou
    JOURNAL OF NEPHROLOGY, 2008, 21 (04) : 543 - 549
  • [39] Comment on:: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease -: Reply
    Cremieux, Pierre-Yves
    Van Audenrode, Marc
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (07) : 1573 - 1574
  • [40] Development of a strategy to successfully convert an ambulatory infusion center from procrit (epoetin alfa) to aranesp (darbepoetin alfa).
    Longfield, V
    Gebhart, B
    Hayward, L
    ONCOLOGY NURSING FORUM, 2005, 32 (02) : 470 - 470
12345